Health Care Weekly: HHS OIG Requests Information on Direct-To-Consumer Drug Sales, Anti-Kickback Laws; CMS Seeks to Break AMA Monopoly on Coding and Payments; CMS to Propose Rule Loosening Conditions for Participation in Medicare, Medicaid; FTC Settles With Caremark; FDA to Defend Legal Authority to Publish CRLs; FDA Cracks Down on Online Ketamine Sales; FDA Issues Guidance, Schedules Hearing on Psychedelic Research and Usage

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • HHS OIG may seek to update anti-kickback regulations to accommodate DTC drug sales. • CMS proposes breaking AMA monopoly on CPT codes and RUC. […]